X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33111) 33111
Book Review (6453) 6453
Newspaper Article (4583) 4583
Newsletter (4572) 4572
Publication (2084) 2084
Trade Publication Article (415) 415
Book Chapter (339) 339
Web Resource (265) 265
Conference Proceeding (180) 180
Magazine Article (167) 167
Book / eBook (131) 131
Transcript (53) 53
Dissertation (28) 28
Reference (4) 4
Report (3) 3
Data Set (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24150) 24150
humans (23687) 23687
lymphomas (17599) 17599
female (11237) 11237
male (11224) 11224
oncology (10898) 10898
middle aged (9746) 9746
cancer (8774) 8774
hematology (8558) 8558
aged (8200) 8200
adult (8161) 8161
lymphoma (7109) 7109
follicular lymphoma (5229) 5229
research (4912) 4912
non-hodgkin's lymphomas (4728) 4728
non-hodgkins-lymphoma (4539) 4539
chemotherapy (4538) 4538
pathology (4491) 4491
care and treatment (4307) 4307
prognosis (3963) 3963
rituximab (3739) 3739
b-cell lymphoma (3648) 3648
leukemia (3592) 3592
aged, 80 and over (3534) 3534
animals (3025) 3025
immunohistochemistry (2852) 2852
treatment outcome (2731) 2731
abridged index medicus (2719) 2719
antineoplastic combined chemotherapy protocols - therapeutic use (2567) 2567
diagnosis (2533) 2533
analysis (2501) 2501
tumors (2501) 2501
adolescent (2459) 2459
expression (2458) 2458
medical research (2419) 2419
lymphoma, follicular - pathology (2369) 2369
chronic lymphocytic-leukemia (2298) 2298
medicine & public health (2149) 2149
immunology (2103) 2103
patients (2084) 2084
retrospective studies (2035) 2035
genetic aspects (2013) 2013
health aspects (1993) 1993
apoptosis (1986) 1986
survival (1975) 1975
clinical trials (1957) 1957
disease (1910) 1910
hemic and lymphatic diseases (1885) 1885
reports (1855) 1855
therapy (1850) 1850
t cells (1840) 1840
antineoplastic agents - therapeutic use (1799) 1799
lymphoma, non-hodgkin - pathology (1776) 1776
risk factors (1774) 1774
transplantation (1752) 1752
lymphoma - pathology (1741) 1741
diagnosis, differential (1730) 1730
immunotherapy (1706) 1706
lymphocytes (1704) 1704
lymphoma, b-cell - pathology (1699) 1699
neoplasm staging (1581) 1581
gene expression (1572) 1572
pharmaceutical industry (1550) 1550
mice (1549) 1549
young adult (1546) 1546
drug therapy (1516) 1516
medicine, experimental (1516) 1516
biopsy (1477) 1477
antineoplastic agents (1467) 1467
mutation (1465) 1465
classification (1448) 1448
child (1442) 1442
lymphoma, follicular - drug therapy (1412) 1412
antimitotic agents (1409) 1409
antibodies, monoclonal - therapeutic use (1408) 1408
stem cells (1377) 1377
cell biology (1373) 1373
disease-free survival (1348) 1348
non-hodgkin's lymphoma (1342) 1342
lymphoma, large b-cell, diffuse - pathology (1333) 1333
cancer therapies (1318) 1318
lymph nodes - pathology (1301) 1301
lymphoma, follicular - genetics (1299) 1299
translocation, genetic (1296) 1296
lymphoma, non-hodgkin - drug therapy (1253) 1253
polymerase chain reaction (1253) 1253
follow-up studies (1220) 1220
article (1213) 1213
flow cytometry (1213) 1213
non-hodgkin lymphoma (1209) 1209
immunophenotyping (1185) 1185
proteins (1163) 1163
immune system diseases (1160) 1160
lymphoma, b-cell - genetics (1148) 1148
universities and colleges (1147) 1147
survival analysis (1140) 1140
antibodies, monoclonal, murine-derived (1128) 1128
dermatology (1126) 1126
studies (1111) 1111
lymphocytes b (1107) 1107
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Scarborough Hospital - Hospital Department (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41773) 41773
German (399) 399
French (368) 368
Japanese (289) 289
Spanish (190) 190
Chinese (131) 131
Russian (120) 120
Italian (118) 118
Korean (52) 52
Polish (47) 47
Czech (41) 41
Portuguese (28) 28
Hungarian (18) 18
Romanian (12) 12
Dutch (11) 11
Turkish (10) 10
Danish (8) 8
Serbian (6) 6
Norwegian (5) 5
Bulgarian (4) 4
Croatian (4) 4
Finnish (3) 3
Slovak (3) 3
Swedish (3) 3
Bosnian (2) 2
Latvian (2) 2
Arabic (1) 1
Hebrew (1) 1
Manx (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 216 - 225
Abstract Background Randomised trials of rituximab maintenance (MR) for patients with follicular lymphoma support improved progression-free survival (PFS), but... 
Hematology, Oncology and Palliative Medicine | Follicular lymphoma | Rituximab | Maintenance | Meta-analysis | TRIAL | MULTICENTER | ONCOLOGY | OPEN-LABEL | PHASE-3 | INDOLENT | EVENT | Immunocompromised Host - immunology | Doxorubicin - therapeutic use | Multivariate Analysis | Cyclophosphamide - administration & dosage | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Induction Chemotherapy | Male | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Infection - etiology | Young Adult | Rituximab - therapeutic use | Infection - epidemiology | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Maintenance Chemotherapy | Prednisone - administration & dosage | Proportional Hazards Models | Lymphoma, Follicular - mortality | Survival Rate | Randomized Controlled Trials as Topic | Rituximab - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Medical policy | Patient outcomes | Analysis | Oncology, Experimental | Lymphomas | Research | Epidemiology | Cancer | Therapy | Data analysis | Clinical trials | Data processing | Infections | Lymphoma | Patients | Survival | Subgroups | Randomization | Index Medicus
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2014, Volume 20, Issue 11, pp. 2862 - 2872
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2014, Volume 132, Issue 7, pp. 851 - 858
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 05/2009, Volume 33, Issue 5, pp. 682 - 690
Rare cases of peripheral T-cell lymphomas with follicular growth pattern (PTCL-F) have been recently reported, and their association with t(5;9)(q33;q22)... 
Angioimmunoblastic T-cell lymphoma | Follicular helper T cell | Peripheral T-cell lymphoma | SURGERY | SYK | MARKER | angioimmunoblastic T-cell lymphoma | PHENOTYPE | peripheral T-cell lymphoma | PATHOLOGY | GENE-EXPRESSION ANALYSIS | GRADIENT GEL-ELECTROPHORESIS | follicular helper T cell | CXC CHEMOKINE RECEPTOR-5 | NEOPLASTIC-CELLS | RESPONSES | POLYMERASE-CHAIN-REACTION | PD-1 | Inducible T-Cell Co-Stimulator Protein | Translocation, Genetic | Humans | Middle Aged | Apoptosis Regulatory Proteins - analysis | Gene Expression Regulation, Neoplastic | Chemokine CXCL13 - analysis | DNA-Binding Proteins - analysis | Antigens, CD - analysis | Antigens, Differentiation, T-Lymphocyte - analysis | Lymphoma, Follicular - genetics | T-Lymphocytes, Helper-Inducer - immunology | Aged, 80 and over | Adult | Immunoblastic Lymphadenopathy - pathology | T-Lymphocytes, Helper-Inducer - pathology | Immunoblastic Lymphadenopathy - genetics | Lymphoma, Follicular - pathology | Europe | Gene Rearrangement, T-Lymphocyte | Neprilysin - analysis | Lymphoma, T-Cell, Peripheral - genetics | Genotype | Immunophenotyping | In Situ Hybridization, Fluorescence | Chromosomes, Human, Pair 9 | Chromosomes, Human, Pair 5 | Phenotype | Lymphoma, Follicular - immunology | Biopsy | CD4 Antigens - analysis | Lymphoma, T-Cell, Peripheral - pathology | Programmed Cell Death 1 Receptor | Aged | Immunoblastic Lymphadenopathy - immunology | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - immunology | Proto-Oncogene Proteins c-bcl-6 | Index Medicus | Lymphoma, T-Cell, Peripheral | Antigens, Differentiation, T-Lymphocyte | Life Sciences | DNA-Binding Proteins | Chemokine CXCL13 | Immunoblastic Lymphadenopathy | Antigens, CD4 | Biochemistry, Molecular Biology | T-Lymphocytes, Helper-Inducer | Apoptosis Regulatory Proteins | Lymphoma, Follicular | Neprilysin | Antigens, CD
Journal Article